Inhaled Antibiotic Therapy in Chronic Respiratory Diseases
The management of patients with chronic respiratory diseases affected by difficult to treat infections has become a challenge in clinical practice. Conditions such as cystic fibrosis (CF) and non-CF bronchiectasis require extensive treatment strategies to deal with multidrug resistant pathogens that...
Main Authors: | Diego J. Maselli, Holly Keyt, Marcos I. Restrepo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/18/5/1062 |
Similar Items
-
Impact of concomitant nontuberculous mycobacteria and Pseudomonas aeruginosa isolates in non-cystic fibrosis bronchiectasis
by: Hsieh MH, et al.
Published: (2018-08-01) -
Outcomes of pulmonary Mycobacterium abscessus infection
by: William G Flight, et al.
Published: (2020-01-01) -
An evaluation of methods for the isolation of nontuberculous mycobacteria from patients with cystic fibrosis, bronchiectasis and patients assessed for lung transplantation
by: D. Stephenson, et al.
Published: (2019-01-01) -
Gender susceptibility to mycobacterial infections in patients with non-CF bronchiectasis
by: Mehdi Mirsaeidi, et al.
Published: (2015-01-01) -
Interaction of South Asian spices with conventional antibiotics: Implications for antimicrobial resistance for Mycobacterium abscessus and cystic fibrosis
by: Rachel Ellen Moore, et al.
Published: (2018-01-01)